Clinical Significance of Additional Cytogenetic Abnormalities (ACA) at Disease Progression in Patients with High-Risk Myelodysplastic Syndrome (MDS) Treated with Azacitidine

被引：0
|
作者：
Naito, Chiaki [1 ]
Shimizu, Hiroaki [2 ]
Miyazawa, Yuri [3 ]
Ishizaki, Takuma [4 ]
Yokohama, Akihiko [5 ]
Saito, Takayuki [6 ]
Tsukamoto, Norifumi [7 ]
Handa, Hiroshi [8 ]
机构：
[1] Gunma Univ Hosp, Dept Hematol, Maebashi, Gumma, Japan
[2] Gunma Univ, Dept Hematol, Grad Sch Med, Maebashi, Gunma, Japan
[3] Gunma Univ Hosp, Dept Hematol, Masbashi, Gunma, Japan
[4] Gunma Univ Hosp, Dept Hematol, Maebashi, Gumma, Japan
[5] Gunma Univ Hosp, Blood Transfus Serv, Maebashi, Gumma, Japan
[6] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gumma, Japan
[7] Gunma Univ Hosp, Ctr Oncol, Maebashi, Gumma, Japan
[8] Gunma Univ, Dept Hematol, Grad Sch Med, Maebashi, Gumma, Japan
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127956
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5434
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
    Yan, Xuefen
    Wang, Lu
    Jiang, Lingxu
    Luo, Yingwan
    Lin, Peipei
    Yang, Wenli
    Ren, Yanling
    Ma, Liya
    Zhou, Xinping
    Mei, Chen
    Ye, Li
    Xu, Gaixiang
    Xu, Weilai
    Yang, Haiyang
    Lu, Chenxi
    Jin, Jie
    Tong, Hongyan
    CANCER MEDICINE, 2021, 10 (05): : 1759 - 1771
  • [42] Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
    Jain, Akriti G.
    Ball, Somedeb
    Aguirre, Luis
    Al Ali, Najla
    Kaldas, David
    Tinsley-Vance, Sara
    Kuykendall, Andrew
    Chan, Onyee
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2157 - 2164
  • [43] Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
    Jain, Akriti G.
    Ball, Somedeb
    Aguirre, Luis
    Al Ali, Najla
    Kaldas, David
    Tinsley-Vance, Sara
    Kuykendall, Andrew
    Chan, Onyee
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami
    HAEMATOLOGICA, 2024, 109 (07) : 2157 - 2164
  • [44] CYTOGENETIC STUDIES IN MYELODYSPLASTIC SYNDROME (IV) - PROGNOSTIC AND CLINICAL-SIGNIFICANCE OF CHROMOSOME-ABNORMALITIES
    TANIWAKI, M
    HORIIKE, S
    INAZAWA, J
    OKUDA, T
    YASHIGE, H
    YOKOTA, S
    NISHIDA, K
    SONODA, Y
    MISAWA, S
    ABE, T
    TAKINO, T
    JAPANESE JOURNAL OF HUMAN GENETICS, 1986, 31 (02): : 156 - 156
  • [45] Effect of azacitidine on PI-PLC-beta1 expression and Akt activation in a patient affected by high-risk myelodysplastic syndrome (MDS)
    Finelli, C.
    Follo, M. Y.
    Mongiorgi, S.
    Bosi, C.
    Martinelli, G.
    Baccarani, M.
    Martelli, A. M.
    Cocco, L.
    LEUKEMIA RESEARCH, 2007, 31 : S72 - S73
  • [46] The Prognostic Value of Monosomal Karyotype (MK) in High-Risk Patients with Myelodysplastic Syndromes Treated with 5-Azacitidine
    Papageorgiou, Sotirios
    Kontos, Christos K.
    Tsiambalis, Thomas
    Vyniou, Athina
    Symeonidis, Argiris
    Galanopoulos, Athanasios
    Kotsianidis, Ioannis
    Pappa, Vassiliki
    BLOOD, 2017, 130
  • [47] Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes
    Navada, Shyamala C.
    Silverman, Lewis R.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2017, 8 (01) : 21 - 27
  • [48] Clinical significance of CD41-positive blasts in association with a monosomal karyotype in patients with myelodysplastic syndrome treated with azacitidine
    Ogata, Kiyoyuki
    Sei, Kazuma
    Kawahara, Naoya
    Yamamoto, Yumi
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) : E142 - E145
  • [49] Rare lobular capillary hemangioma associated with azacitidine in high-risk myelodysplastic syndrome patient
    Grafanaki, Katerina
    Kourakli, Alexandra
    Skeparnias, Ilias
    Spiliopoulos, Theofanis
    Koumoundourou, Dimitra
    Bravou, Vasiliki
    Alexopoulos, Angelos
    Symeonidis, Argiris
    Georgiou, Sophia
    DERMATOLOGIC THERAPY, 2021, 34 (02)
  • [50] Intensive therapy for high-risk myelodysplastic syndromes and the biological significance of karyotype abnormalities
    Hiddemann, W
    Jahns-Streubel, G
    Verbeek, W
    Wörmann, B
    Haase, D
    Schoch, C
    LEUKEMIA RESEARCH, 1998, 22 : S23 - S26
12345